Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Curfman

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Biophysical Journal|December 22, 2016
Methyl-CpG/MBD2 Interaction Requires Minimum Separation and Exhibits Minimal Sequence SpecificityBlythe Moreland, Kenji Oman, John Curfman, et al.
BMC Genomics|January 4, 2013
Enrichment-based DNA methylation analysis using next-generation sequencing: sample exclusion, estimating changes in global methylation, and the contribution of replicate lanesMichael P Trimarchi, Mark Murphy, David Frankhouser, et al.
IEEE International Workshop on Genomic Signal Processing and Statistics : [Proceedings]. IEEE International Workshop on Genomic Signal Processing and Statistics|April 10, 2012
A Scalable, Flexible Workflow for MethylCap-Seq Data AnalysisBenjamin Rodriguez, Hok-Hei Tam, David Frankhouser, et al.
Bioinformatics (Oxford, England)|September 3, 2014
PrEMeR-CG: inferring nucleotide level DNA methylation values from MethylCap-seq dataDavid E Frankhouser, Mark Murphy, James S Blachly, et al.
BMC Genomics|November 9, 2012
Methods for high-throughput MethylCap-Seq data analysisBenjamin A T Rodriguez, David Frankhouser, Mark Murphy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2010
Dose escalation of lenalidomide in relapsed or refractory acute leukemiasWilliam Blum, Rebecca B Klisovic, Heiko Becker, et al.
Blood|July 13, 2012
Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemiaPearlly Yan, David Frankhouser, Mark Murphy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2011
TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B studyKlaus H Metzeler, Kati Maharry, Michael D Radmacher, et al.
Blood|November 20, 2012
inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutationsSebastian Schwind, Colin G Edwards, Deedra Nicolet, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biophysical Journal|December 22, 2016
Methyl-CpG/MBD2 Interaction Requires Minimum Separation and Exhibits Minimal Sequence SpecificityBlythe Moreland, Kenji Oman, John Curfman, et al.
BMC Genomics|January 4, 2013
Enrichment-based DNA methylation analysis using next-generation sequencing: sample exclusion, estimating changes in global methylation, and the contribution of replicate lanesMichael P Trimarchi, Mark Murphy, David Frankhouser, et al.
IEEE International Workshop on Genomic Signal Processing and Statistics : [Proceedings]. IEEE International Workshop on Genomic Signal Processing and Statistics|April 10, 2012
A Scalable, Flexible Workflow for MethylCap-Seq Data AnalysisBenjamin Rodriguez, Hok-Hei Tam, David Frankhouser, et al.
Bioinformatics (Oxford, England)|September 3, 2014
PrEMeR-CG: inferring nucleotide level DNA methylation values from MethylCap-seq dataDavid E Frankhouser, Mark Murphy, James S Blachly, et al.
BMC Genomics|November 9, 2012
Methods for high-throughput MethylCap-Seq data analysisBenjamin A T Rodriguez, David Frankhouser, Mark Murphy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2010
Dose escalation of lenalidomide in relapsed or refractory acute leukemiasWilliam Blum, Rebecca B Klisovic, Heiko Becker, et al.
Blood|July 13, 2012
Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemiaPearlly Yan, David Frankhouser, Mark Murphy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2011
TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B studyKlaus H Metzeler, Kati Maharry, Michael D Radmacher, et al.
Blood|November 20, 2012
inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutationsSebastian Schwind, Colin G Edwards, Deedra Nicolet, et al.
Pageof 1